Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI

Development and validation of RP-HPLC method for the estimation of Erlotinib in pharmaceutical formulation

(2017) S.T. Latha et al.   Arabian Journal of Chemistry

Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors

(2016) Yuanbiao Tu et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors

(2016) Xuemei Qin et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination

(2016) Ahmed Atef Ahmed Ali et al.   PLoS One

In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles

(2015) Yunkai Zhu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

RasGRP1 opposes proliferative EGFR–SOS1–Ras signals and restricts intestinal epithelial cell growth

(2015) Philippe Depeille et al.   NATURE CELL BIOLOGY

MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription

(2015) X Cheng et al.   ONCOGENE

Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

(2015) G Sette et al.   Cell Death & Disease

Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice

(2015) Vijayendra Agrawal et al.   Oncotarget

Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery

(2014) Harald Unterweger et al.   International Journal of Nanomedicine

Casein-Coated Iron Oxide Nanoparticles for High MRI Contrast Enhancement and Efficient Cell Targeting

(2013) Jing Huang et al.   ACS Applied Materials & Interfaces

Theranostic Nanoparticles with Controlled Release of Gemcitabine for Targeted Therapy and MRI of Pancreatic Cancer

(2013) Gee Young Lee et al.   ACS Nano

EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy

(2013) T Kumai et al.   BRITISH JOURNAL OF CANCER

A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate

(2013) Jing Li et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

(2013) Neal I. Lindeman et al.   Journal of Thoracic Oncology

Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer

(2013) Parvin Ataie-Kachoie et al.   MOLECULAR CANCER RESEARCH

Theranostic applications of nanoparticles in cancer

(2012) Naveed Ahmed et al.   DRUG DISCOVERY TODAY

The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells

(2012) Shuiqing Hu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Direct synthesis of dextran-coated superparamagnetic iron oxide nanoparticles in a capillary-based droplet reactor

(2012) Kritika Kumar et al.   JOURNAL OF MATERIALS CHEMISTRY

Dextran-Coated Iron Oxide Nanoparticles: A Versatile Platform for Targeted Molecular Imaging, Molecular Diagnostics, and Therapy

(2011) Carlos Tassa et al.   ACCOUNTS OF CHEMICAL RESEARCH

Smart Multifunctional Hollow Microspheres for the Quick Release of Drugs in Intracellular Lysosomal Compartments

(2011) Cherng-Jyh Ke et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin

(2011) Jian-Hong Zuo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer

(2011) Rodrigo Dienstmann et al.   Molecular Oncology

Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells

(2011) Y.-C. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nanoparticle-based theranostic agents

(2010) Jin Xie et al.   ADVANCED DRUG DELIVERY REVIEWS

Biological Properties of Iron Oxide Nanoparticles for Cellular and Molecular Magnetic Resonance Imaging

(2010) Thomas Schlorf et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

XIAP as a ubiquitin ligase in cellular signaling

(2009) S Galbán et al.   CELL DEATH AND DIFFERENTIATION

Entrapment of Hydrophobic Drugs in Nanoparticle Monolayers with Efficient Release into Cancer Cells

(2009) Chae Kyu Kim et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Biofunctionalized targeted nanoparticles for therapeutic applications

(2008) Andrew Z Wang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Polyplexes from Poly(aspartamide) Bearing 1,2-Diaminoethane Side Chains Induce pH-Selective, Endosomal Membrane Destabilization with Amplified Transfection and Negligible Cytotoxicity

(2008) Kanjiro Miyata et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1

(2008) K-Y Tai et al.   ONCOGENE

Inhibition of Tumor-Cell Invasion with Chlorotoxin-Bound Superparamagnetic Nanoparticles

(2008) Omid Veiseh et al.   Small